Skip to main content
. 2017 Jan 18;13(3):1949–1957. doi: 10.3892/ol.2017.5616

Figure 4.

Figure 4.

Unadjusted Kaplan-Meier estimator survival curves and HRs for the association between total serum testosterone levels and (A) disease progression, (B) mortality from all causes and (C) mortality due to prostate cancer. HR, hazard ratio; CI, confidence interval.